Introduction: Early assessment of Systemic Inflammatory Response Syndrome (SIRS) through various biomarkers like Procalcitonin (PCT), C-reactive Protein (CRP), Interleukin-1 (IL-1) etc., is crucial to manage the outcome of patients. Levels of PCT concerning its likelihood to distinguish patients with SIRS and non-SIRS and the possibility to predict mortality in patients with sepsis has been variable. Aim: To investigate the role of PCT in early diagnosis of sepsis in patients admitted to Intensive Care Unit (ICU). Materials and Methods: In this prospective observational study, 136 patients hospitalised in ICU at Vydehi Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India, between July 2019 to June 2020 ...
Sepsis is a leading cause of mortality in critically ill patients. Delay in diagnosis and initiation...
Background: Quick diagnosis of sepsis in intensive care unit patients is challenging for physicians....
INTRODUCTION. The ideal sepsis biomarker still has to be born. The need of a useful and reliable cli...
Introduction: During infection, there is increased expression of CALC-I gene resulting in ubiquitous...
Introduction The diagnosis of sepsis in critically ill patients is challenging because traditional m...
Introduction The diagnosis of sepsis in critically ill patients is challenging because traditional m...
Introduction: In critically-ill patients, procalcitonin has been studied as an assessment of appropr...
Introduction: In critically-ill patients, procalcitonin has been studied as an assessment of appropr...
Context: Rapid treatment of sepsis is of crucial importance for survival of patients. Specific and r...
Context: Rapid treatment of sepsis is of crucial importance for survival of patients. Specific and r...
Context: Rapid treatment of sepsis is of crucial importance for survival of patients. Specific and r...
Introduction. The diagnosis of sepsis in critically ill patients is challenging because traditional ...
Abstract- Procalcitonin (PCT) is a precursor peptide for the hormone calcitonin and is frequently in...
We studied the usefulness of serum procalcitonin (PCT), interleukin-6 (IL-6), lipopolysaccharide bi...
Procalcitonin (PCT) is a precursor peptide for the hormone calcitonin and is frequently increased in...
Sepsis is a leading cause of mortality in critically ill patients. Delay in diagnosis and initiation...
Background: Quick diagnosis of sepsis in intensive care unit patients is challenging for physicians....
INTRODUCTION. The ideal sepsis biomarker still has to be born. The need of a useful and reliable cli...
Introduction: During infection, there is increased expression of CALC-I gene resulting in ubiquitous...
Introduction The diagnosis of sepsis in critically ill patients is challenging because traditional m...
Introduction The diagnosis of sepsis in critically ill patients is challenging because traditional m...
Introduction: In critically-ill patients, procalcitonin has been studied as an assessment of appropr...
Introduction: In critically-ill patients, procalcitonin has been studied as an assessment of appropr...
Context: Rapid treatment of sepsis is of crucial importance for survival of patients. Specific and r...
Context: Rapid treatment of sepsis is of crucial importance for survival of patients. Specific and r...
Context: Rapid treatment of sepsis is of crucial importance for survival of patients. Specific and r...
Introduction. The diagnosis of sepsis in critically ill patients is challenging because traditional ...
Abstract- Procalcitonin (PCT) is a precursor peptide for the hormone calcitonin and is frequently in...
We studied the usefulness of serum procalcitonin (PCT), interleukin-6 (IL-6), lipopolysaccharide bi...
Procalcitonin (PCT) is a precursor peptide for the hormone calcitonin and is frequently increased in...
Sepsis is a leading cause of mortality in critically ill patients. Delay in diagnosis and initiation...
Background: Quick diagnosis of sepsis in intensive care unit patients is challenging for physicians....
INTRODUCTION. The ideal sepsis biomarker still has to be born. The need of a useful and reliable cli...